CBD Shows Inconsistent Effects on Cognition Across 36 Randomized Trials
A review of 36 randomized controlled trials found CBD had variable effects on cognition depending on the condition and dose, with no consistent cognitive enhancement across populations.
Quick Facts
What This Study Found
In healthy participants, CBD showed some effects on cognitive function and sleep quality with various dosing strategies. In Parkinson's disease, 75-300 mg improved daily activities. CBD at 300-400 mg decreased subjective anxiety in psychiatric patients. In psychosis, 600 mg showed inconsistent cognitive results. Up to 1000 mg in schizophrenia and 800 mg in substance use disorders had minimal cognitive effects.
Key Numbers
1,038 articles screened, 36 included. Doses ranged from 75 mg to 1,000 mg. Parkinson's: 75-300 mg improved daily activities. Psychiatric: 300-400 mg reduced anxiety. Psychosis: 600 mg inconsistent. Schizophrenia: up to 1,000 mg minimal cognitive effect. Substance use: up to 800 mg minimal cognitive effect.
How They Did This
Literature review of 36 randomized controlled trials identified from PubMed/Medline using specified search terms. Studies included healthy participants and those with neurological disease, psychiatric disease, psychosis, schizophrenia, and substance use disorders.
Why This Research Matters
CBD is increasingly marketed for cognitive benefits, but this review of actual RCT data shows the evidence is far more nuanced, with effects varying widely by dose, condition, and outcome measure.
The Bigger Picture
The highly variable results across conditions and doses underscore the need for standardized formulations and dosing protocols before any claims about CBD's cognitive effects can be made with confidence.
What This Study Doesn't Tell Us
Most studies used acute (single-dose) protocols. Wide variation in CBD dose, formulation, and route of administration. Different cognitive assessments across studies make comparison difficult. Publication bias not formally assessed.
Questions This Raises
- ?Would standardized chronic dosing protocols produce more consistent cognitive outcomes?
- ?Do different CBD formulations produce different cognitive effects?
Trust & Context
- Key Stat:
- Evidence Grade:
- Reviews RCT-level evidence across multiple conditions, but highly heterogeneous methods and inconsistent findings limit the overall strength to moderate.
- Study Age:
- Reviews RCTs available through recent literature search.
- Original Title:
- Cannabidiol and cognition: a literature review of human randomized controlled trials.
- Published In:
- Behavioural pharmacology, 36(5), 203-216 (2025)
- Authors:
- Singh, Jyotpal(2), Ellingson, Chase J, Shafiq, M Abdullah, Alcorn, Jane, Neary, J Patrick
- Database ID:
- RTHC-07669
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does CBD improve brain function?
The evidence is mixed. Across 36 clinical trials, CBD showed some benefits for anxiety and Parkinson's disease activities but had minimal or inconsistent effects on cognition in most other conditions studied.
What dose of CBD affects cognition?
Effects varied widely: 75-300 mg showed some benefits in Parkinson's, 300-400 mg reduced anxiety, but doses up to 1,000 mg had minimal cognitive effects in schizophrenia. No single optimal cognitive dose has been established.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07669APA
Singh, Jyotpal; Ellingson, Chase J; Shafiq, M Abdullah; Alcorn, Jane; Neary, J Patrick. (2025). Cannabidiol and cognition: a literature review of human randomized controlled trials.. Behavioural pharmacology, 36(5), 203-216. https://doi.org/10.1097/FBP.0000000000000837
MLA
Singh, Jyotpal, et al. "Cannabidiol and cognition: a literature review of human randomized controlled trials.." Behavioural pharmacology, 2025. https://doi.org/10.1097/FBP.0000000000000837
RethinkTHC
RethinkTHC Research Database. "Cannabidiol and cognition: a literature review of human rand..." RTHC-07669. Retrieved from https://rethinkthc.com/research/singh-2025-cannabidiol-and-cognition-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.